Regulus Therapeutics

📍 San Diego, United States🗓 Founded 2007👥 42 employees💰 Last funded Jun 2019
Biotechnology Research🌐 regulusrx.com
Website LinkedIn
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is located in San Diego, California and is led by a seasoned executive team experienced in corporate management, business, science, drug discovery and development. Regulus​ scientific advisory board consists of world-class scientists and some of the foremost authorities in the field of microRNA research.
4
Total investors
0
Early stage
0
Mid stage
2
Late stage
2007
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2013–2019 · investors recorded per year
20131201712018120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Regulus Therapeutics?
Regulus Therapeutics has 4 investors on record on gritt.io and 2 late-stage investors.
When did Regulus Therapeutics last raise funding?
The most recent investment in Regulus Therapeutics recorded on gritt.io was in June 2019.
When was Regulus Therapeutics founded?
Regulus Therapeutics was founded in 2007.
What industry is Regulus Therapeutics in?
Regulus Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Regulus Therapeutics based?
Regulus Therapeutics is headquartered in San Diego, United States.